These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21151479)

  • 41. HPV primary cervical screening in England: Women's awareness and attitudes.
    Patel H; Moss EL; Sherman SM
    Psychooncology; 2018 Jun; 27(6):1559-1564. PubMed ID: 29521462
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
    BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ensuring a Successful Transition From Cytology to Human Papillomavirus-Based Primary Cervical Cancer Screening in Canada by Investigating the Psychosocial Correlates of Women's Intentions: Protocol for an Observational Study.
    Griffin-Mathieu G; Haward B; Tatar O; Zhu P; Perez S; Shapiro GK; McBride E; Thompson EL; Smith LW; Lofters AK; Daley EM; Guichon JR; Waller J; Steben M; Decker KM; Mayrand MH; Brotherton JML; Ogilvie GS; Zimet GD; Norris T; Rosberger Z
    JMIR Res Protoc; 2022 Jun; 11(6):e38917. PubMed ID: 35708742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.
    Ho GY; Burk RD; Klein S; Kadish AS; Chang CJ; Palan P; Basu J; Tachezy R; Lewis R; Romney S
    J Natl Cancer Inst; 1995 Sep; 87(18):1365-71. PubMed ID: 7658497
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
    Lilliecreutz C; Karlsson H; Spetz Holm AC
    PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial.
    Porras C; Tsang SH; Herrero R; Guillén D; Darragh TM; Stoler MH; Hildesheim A; Wagner S; Boland J; Lowy DR; Schiller JT; Schiffman M; Schussler J; Gail MH; Quint W; Ocampo R; Morales J; Rodríguez AC; Hu S; Sampson JN; Kreimer AR;
    Lancet Oncol; 2020 Dec; 21(12):1643-1652. PubMed ID: 33271093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Young Danish HPV vaccinated women's knowledge, barriers and facilitators towards cervical cancer screening: A qualitative study.
    Mortensen JH; Bigaard J; Kvernrød AB
    Prev Med Rep; 2021 Dec; 24():101507. PubMed ID: 34430190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Knowledge and experience of a cohort of HIV-positive and HIV-negative Ghanaian women after undergoing human papillomavirus and cervical cancer screening.
    Stuart A; Obiri-Yeboah D; Adu-Sarkodie Y; Hayfron-Benjamin A; Akorsu AD; Mayaud P
    BMC Womens Health; 2019 Oct; 19(1):123. PubMed ID: 31647013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The efficacy of human papillomavirus vaccination in the prevention of recurrence of severe cervical lesions.
    Sehnal Borek; Pichlík Tomáš; Halaška Michael J; Větrovská Monika; Babková Anna; Drozenová Jana; Robová Helena; Rob Lukáš
    Ceska Gynekol; 2023; 88(4):294-300. PubMed ID: 37643912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
    Busolo D; Woodgate R
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Testing positive for Human Papillomavirus (HPV) at primary HPV cervical screening: A qualitative exploration of women's information needs and preferences for communication of results.
    Mulcahy Symmons S; Waller J; McBride E
    Prev Med Rep; 2021 Dec; 24():101529. PubMed ID: 34976606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of Human Papillomavirus (HPV) and Other Sexually Transmitted Infections (STIs) among Italian Women Referred for a Colposcopy.
    Martinelli M; Musumeci R; Sechi I; Sotgiu G; Piana A; Perdoni F; Sina F; Fruscio R; Landoni F; Cocuzza CE
    Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31818033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Access to information by women with HPV, cervical dysplasia and cancer in situ].
    Castro-Vásquez Mdel C; Arellano-Gálvez Mdel C
    Salud Publica Mex; 2010; 52(3):207-12. PubMed ID: 20485883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of sexually transmitted infections and human papillomavirus co-infection with abnormal cervical cytology among women in Saudi Arabia.
    Alotaibi HJ; Almajhdi FN; Alsaleh AN; Obeid DA; Khayat HH; Al-Muammer TA; Tulbah AM; Alfageeh MB; Al-Ahdal MN; Alhamlan FS
    Saudi J Biol Sci; 2020 Jun; 27(6):1587-1595. PubMed ID: 32489299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reproductive health needs of Human papillomavirus (HPV) positive women: A systematic review.
    Galeshi M; Shirafkan H; Yazdani S; Motaghi Z
    PLoS One; 2022; 17(9):e0266819. PubMed ID: 36095006
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Information needs of young women vaccinated against HPV attending colposcopy: a qualitative study.
    Young A; Cotton S; Cruickshank ME
    BMC Womens Health; 2018 Dec; 18(1):200. PubMed ID: 30541542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study.
    Kwan TT; Cheung AN; Lo SS; Lee PW; Tam KF; Chan KK; Ngan HY
    Acta Obstet Gynecol Scand; 2011 May; 90(5):445-51. PubMed ID: 21306349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: a prospective cohort study.
    Matsumoto K; Oki A; Furuta R; Maeda H; Yasugi T; Takatsuka N; Mitsuhashi A; Fujii T; Hirai Y; Iwasaka T; Yaegashi N; Watanabe Y; Nagai Y; Kitagawa T; Yoshikawa H;
    Int J Cancer; 2011 Jun; 128(12):2898-910. PubMed ID: 20734388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women.
    Blitz S; Baxter J; Raboud J; Walmsley S; Rachlis A; Smaill F; Ferenczy A; Coutlée F; Hankins C; Money D;
    J Infect Dis; 2013 Aug; 208(3):454-62. PubMed ID: 23624362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.